[Nephrocalcinosis and clinical significance in early chronic renal disease]
- PMID: 8124612
[Nephrocalcinosis and clinical significance in early chronic renal disease]
Abstract
Kidney tissue calcium content from 33 diagnostic human renal biopsies was measured to assess tissue calcium concentration early in the course of human renal disease. Renal calcium content was correlated significantly with serum creatinine (r = 0.71, P < 0.001), serum phosphate (r = 0.64, P < 0.001), and serum Ca x P product (r = 0.66, P < 0.001), but not with serum calcium (r = -0.17, P > 0.05). Threefold greater calcium content was measured in biopsied tissue than in normal renal tissue (315 +/- 169 vs 69 +/- 17 mg/kg renal tissue, P < 0.001). The mean level of serum phosphate and Ca x P product was higher in the patients with significant renal function impairment (Ser > 115 mumol/L) than in patients with normal renal function (1.76 +/- 0.33 mmol/L vs 1.29 +/- 0.18 mmol/L, P < 0.001; 43 +/- 4.7 vs 33 +/- 4.5 mmol 2/L2, P < 0.001, respectively). The mean serum calcium levels were not different in the two groups (1.97 +/- 0.24 mmol/L vs 2.07 +/- 0.16 mmol/L, P > 0.05). The results suggest that renal calcium deposition begins early in the course of various renal diseases, and hence may accelerate progression of chronic renal failure the severity of renal calcium deposition is correlated with hyperphosphatemia and with the level of renal impairment. Dietary phosphate restriction may be necessary early in the course of renal disease.
Similar articles
-
Calcium and phosphorus metabolism in stable renal transplant recipients.Exp Clin Transplant. 2007 Dec;5(2):670-2. Exp Clin Transplant. 2007. PMID: 18194119
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium.Bone. 2007 Oct;41(4):698-703. doi: 10.1016/j.bone.2007.06.014. Epub 2007 Jun 29. Bone. 2007. PMID: 17643363 Clinical Trial.
-
Sevelamer hydrochloride, a phosphate binder, protects against deterioration of renal function in rats with progressive chronic renal insufficiency.Nephrol Dial Transplant. 2003 Oct;18(10):2014-23. doi: 10.1093/ndt/gfg309. Nephrol Dial Transplant. 2003. PMID: 13679475
-
Decreased renal transplant function after parathyroidectomy.Nephrol Dial Transplant. 2007 Feb;22(2):584-91. doi: 10.1093/ndt/gfl583. Epub 2006 Oct 11. Nephrol Dial Transplant. 2007. PMID: 17035377
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources